Exact Mass: 548.3114034

Exact Mass Matches: 548.3114034

Found 500 metabolites which its exact mass value is equals to given mass value 548.3114034, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cymarin

(3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-3-[(2R,4S,5R,6R)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde

C30H44O9 (548.2985174)

Cymarin is a cardenolide glycoside. Cymarin is a natural product found in Apocynum cannabinum, Adonis amurensis, and other organisms with data available. A cardiotonic cardiac glycoside found in STROPHANTHUS. The aglycone is STROPHANTHIN. C - Cardiovascular system > C01 - Cardiac therapy > C01A - Cardiac glycosides > C01AC - Strophanthus glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

Antimycin A

N-{7-hexyl-4,9-dimethyl-8-[(3-methylbutanoyl)oxy]-2,6-dioxo-1,5-dioxonan-3-yl}-2-hydroxy-3-[(hydroxymethylidene)amino]benzene-1-carboximidate

C28H40N2O9 (548.273367)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents

ST 27:0;O6;S

(24R)-3alpha,7alpha,12alpha,24,26-pentahydroxy-5beta-cholestan-27-yl hydrogen sulfate

C27H48O9S (548.3018878)

MPPa (Methyl pyropheophorbide-a)

methyl 3-{16-ethenyl-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetraazahexacyclo[18.2.1.1^{5,8}.1^{10,13}.1^{15,18}.0^{2,6}]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl}propanoate

C34H36N4O3 (548.2787266)

20-Hydroxyganoderic Acid G

(6R)-6-Hydroxy-2-methyl-4-oxo-6-[(3R,5S,7R,10R,12R,13S,14S,17R)-3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid

C30H44O9 (548.2985174)

20-[(3-carbamoyloxy-2-methylbutanoyl)amino]-19-hydroxy-3,5,15-trimethyl-7-methylidene-17-oxoicosa-2,10,12-trienoic acid

C30H48N2O7 (548.3461338)

Peloruside A

C27H48O11 (548.3196458)

A macrolide that is a novel secondary metabolite isolated from a New Zealand marine sponge, Mycale hentscheli.

Caudoside

C30H44O9 (548.2985174)

3,12-O-diacetyl-7-O-(2-methylbutanoyl)-8-O-methylingol

C30H44O9 (548.2985174)

Euphorbia factor L7a

(3beta,5beta,16beta)-3-[(2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy]-14,16-dihydroxycard-20(22)-enolide 16-formate|16-formate 3beta-digitoxosylgitoxigenin|3beta-(beta-D-ribo-2,6-dideoxy-hexopyranosyloxy)-16beta-formyloxy-14-hydroxy-5beta,14beta-card-20(22)-enolide|3beta-(beta-D-ribo-2,6-Didesoxy-hexopyranosyloxy)-16beta-formyloxy-14-hydroxy-5beta,14beta-card-20(22)-enolid|gitoxigenin 16beta-formate 3beta-digitoxoside

C33H40O7 (548.2773890000001)

C30H44O9_(3beta,5beta,8xi,9xi,17alpha)-3-[(6-Deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide

NCGC00384656-01_C30H44O9_(3beta,5beta,8xi,9xi,17alpha)-3-[(6-Deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide

C30H44O9 (548.2985174)

Cymarine

C30H44O9 (548.2985174)

1-[2,4,6-trihydroxy-3-[7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-4-yl]phenyl]dodecan-1-one

C33H40O7 (548.2773890000001)

Cymarine_major

C30H44O9 (548.2985174)

(3R,5R,6R,7S,9S,10R,13R,17R)-17-((R)-5-methoxy-5-oxopentan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,6,7-triyl triacetate

"(3R,5R,6R,7S,9S,10R,13R,17R)-17-((R)-5-methoxy-5-oxopentan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,6,7-triyl triacetate"

C31H48O8 (548.3349008)

Lys-Ser-Leu-Ala-Met

C23H44N6O7S (548.2992034)

peruvoside

C30H44O9 (548.2985174)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides C - Cardiovascular system > C01 - Cardiac therapy > C01A - Cardiac glycosides D002317 - Cardiovascular Agents

(+)-Myristinin A

C32H40N2O6 (548.288622)

bis(lauroyloxy)dimethylstannane

C26H52O4Sn (548.2887382)

belfosdil

C27H50O7P2 (548.303161)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates C93038 - Cation Channel Blocker

C30H44O9 (548.2985174)

Rhamnosyl tetracyclic spinosyn pseudoaglycone

C30H44O9 (548.2985174)

3-[(21S,22S)-16-ethenyl-11,26-diethyl-4-hydroxy-12,17,21-trimethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid

3-[(21S,22S)-16-ethenyl-11,26-diethyl-4-hydroxy-12,17,21-trimethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid

C34H36N4O3 (548.2787266)

Halisulfate 1

C31H48O6S (548.3171428)

(2E,10Z,12E)-20-{[3-(carbamoyloxy)-2-methylbutanoyl]amino}-19-hydroxy-3,5,15-trimethyl-7-methylidene-17-oxoicosa-2,10,12-trienoic acid

C30H48N2O7 (548.3461338)

1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

C32H44N4O4 (548.3362384)

1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

C32H44N4O4 (548.3362384)

1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methyl-3-[(2R)-3-methylbutan-2-yl]urea

C32H44N4O4 (548.3362384)

1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methyl-3-[(2S)-3-methylbutan-2-yl]urea

kalimantacin B

C31H48O8 (548.3349008)

4-[(1r,3s,5s,7s,10s,11r,14r,15r,18r)-7-{[(2r,3r,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-18-hydroxy-10,14-dimethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl]-5h-furan-2-one

4-[(1r,3s,5s,7s,10s,11r,14r,15r,18r)-7-{[(2r,3r,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-18-hydroxy-10,14-dimethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl]-5h-furan-2-one

C30H44O9 (548.2985174)

4-[(1s,2s,4r,5s,6s,9s,10r,13r,15s,18s)-15-{[(2r,3r,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9-hydroxy-5,18-dimethyl-3-oxapentacyclo[8.8.0.0²,⁴.0⁵,⁹.0¹³,¹⁸]octadecan-6-yl]-5h-furan-2-one

4-[(1s,2s,4r,5s,6s,9s,10r,13r,15s,18s)-15-{[(2r,3r,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9-hydroxy-5,18-dimethyl-3-oxapentacyclo[8.8.0.0²,⁴.0⁵,⁹.0¹³,¹⁸]octadecan-6-yl]-5h-furan-2-one

C30H44O9 (548.2985174)

(1r,3r,5r,6ar,7r,8r,9s,10s,10ar)-1-(acetyloxy)-9-(butanoyloxy)-5,10-dihydroxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl butanoate

C30H44O9 (548.2985174)

5-[(1r,3as,3br,5ar,7s,9as,9bs,10r,11ar)-3a,10-dihydroxy-9a,11a-dimethyl-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthren-1-yl]pyran-2-one

C30H44O9 (548.2985174)

2-{[4,5-dihydroxy-2-(hydroxymethyl)-6-{[4-(6-methylhept-5-en-2-yl)cyclohexyl]methoxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C27H48O11 (548.3196458)

anticancer cardiacglycoside pmv70p691-007

C30H44O9 (548.2985174)

{"Ingredient_id": "HBIN016314","Ingredient_name": "anticancer cardiacglycoside pmv70p691-007","Alias": "NA","Ingredient_formula": "C30H44O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1389","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

anticancer cardiacglycoside pmv70p691-008

methyl (6r)-6-[(1r,3s,3ar,4s,5ar,7s,9as,11s,11ar)-3,4,7,11-tetrahydroxy-3a,6,6,9a,11a-pentamethyl-10-oxo-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

C31H48O8 (548.3349008)

(1s,3as,3bs,5ar,7s,9ar,9bs,11as)-7-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

(1s,3as,3bs,5ar,7s,9ar,9bs,11as)-7-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

5,9-dihydroxy-8-(3-hydroxy-4-methylhexan-2-yl)-2-(2-hydroxypropan-2-yl)-4a,10a-dimethyl-9-(2-oxopropyl)-2,3,4,4b,5,11,12,12a-octahydro-1,10-dioxatetraphen-6-one

C31H48O8 (548.3349008)

(1s,4r,5r,6r,10s,12s,13s,15s,16s,18s,21r)-15-hydroxy-4,6,12,17,17-pentamethyl-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan-8-one

(1r,3as,3br,5ar,7s,9ar,9bs,11ar)-7-{[(2r,3r,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

(1r,3as,3br,5ar,7s,9ar,9bs,11ar)-7-{[(2r,3r,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C34H44O6 (548.3137724000001)

(3s)-3-[(4as,6s)-2-hydroxy-7,7-dimethyl-4a,6-bis(3-methylbut-2-en-1-yl)-3-(2-methylpropanoyl)-4-oxo-5,6-dihydrochromen-8-yl]-3-phenylpropanoic acid

C34H44O6 (548.3137724000001)

(1r,3s,4r,7r,9r,11r,13s,14s,15s)-7-[(2e,4s)-4-ethyl-5-hydroxypent-2-en-2-yl]-4,11,13,14-tetrahydroxy-3,9,15-trimethoxy-12,12-dimethyl-6,17-dioxabicyclo[11.3.1]heptadecan-5-one

C27H48O11 (548.3196458)

4-[(1r,3s,5s,7s,10s,11r,14r,15s,18r)-7-{[(2s,3s,4s,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-18-hydroxy-10,14-dimethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl]-5h-furan-2-one

4-[(1r,3s,5s,7s,10s,11r,14r,15s,18r)-7-{[(2s,3s,4s,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-18-hydroxy-10,14-dimethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl]-5h-furan-2-one

C30H44O9 (548.2985174)

(1'r,2's,3s,5's,9'r,12's,13'r,16's,18'r)-2'-hydroxy-16'-{[(2r,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-5-oxo-7'-oxaspiro[oxolane-3,6'-pentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosane]-13'-carbaldehyde

(1'r,2's,3s,5's,9'r,12's,13'r,16's,18'r)-2'-hydroxy-16'-{[(2r,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-5-oxo-7'-oxaspiro[oxolane-3,6'-pentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosane]-13'-carbaldehyde

(5z)-5-[(2e,4e,6e)-9-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-7-methylnona-2,4,6-trien-8-yn-1-ylidene]-3-[(1e)-2-[(1r,2r,4s)-1,2,4-trihydroxy-2,6,6-trimethylcyclohexyl]ethenyl]furan-2-one

C34H44O6 (548.3137724000001)

7-(4-ethyl-5-hydroxypent-2-en-2-yl)-4,11,13,14-tetrahydroxy-3,9,15-trimethoxy-12,12-dimethyl-6,17-dioxabicyclo[11.3.1]heptadecan-5-one

C27H48O11 (548.3196458)

4-[(1r,3s,5s,7s,10s,11s,14r,15r,18r)-7-{[(2s,3s,4s,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-18-hydroxy-10,14-dimethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl]-5h-furan-2-one

4-[(1r,3s,5s,7s,10s,11s,14r,15r,18r)-7-{[(2s,3s,4s,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-18-hydroxy-10,14-dimethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl]-5h-furan-2-one

C30H44O9 (548.2985174)

[(2r,3r)-1-[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-9-(2,5-dihydroxyphenyl)-3,7-dimethylnon-7-en-2-yl]oxysulfonic acid

C31H48O6S (548.3171428)

7-{[3,4-dihydroxy-6-(2-hydroxypropan-2-yl)-4,8a-dimethyl-7-oxo-2,3,4a,8-tetrahydro-1h-naphthalen-2-yl]methyl}-5,6-dihydroxy-3-(2-hydroxypropan-2-yl)-5,8a-dimethyl-4a,6,7,8-tetrahydro-1h-naphthalen-2-one

C30H44O9 (548.2985174)

(2s)-3-[(1r,2s,3s,4r,5s)-2,4-dihydroxy-4-methyl-3,5-bis({[(2z)-2-methylbut-2-enoyl]oxy})cyclohexyl]-1-[(2s)-3,3-dimethyloxiran-2-yl]but-3-en-2-yl (2z)-2-methylbut-2-enoate

C30H44O9 (548.2985174)

4-[(1s,2s,4r,5s,6s,9s,10r,13r,15s,18s)-15-{[(2r,3s,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9-hydroxy-5,18-dimethyl-3-oxapentacyclo[8.8.0.0²,⁴.0⁵,⁹.0¹³,¹⁸]octadecan-6-yl]-5h-furan-2-one

4-[(1s,2s,4r,5s,6s,9s,10r,13r,15s,18s)-15-{[(2r,3s,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9-hydroxy-5,18-dimethyl-3-oxapentacyclo[8.8.0.0²,⁴.0⁵,⁹.0¹³,¹⁸]octadecan-6-yl]-5h-furan-2-one

C30H44O9 (548.2985174)